Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(SYK) inhibitor C61 MeSH Supplementary Concept Data 2025


MeSH Supplementary
(SYK) inhibitor C61
Unique ID
C000715707
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000715707
Entry Term(s)
1,4-Bis (9-O dihydroquinidinyl) phthalazine-hydroquinidine 1,4-phathalazinediyl diether
1,4-bis(9-O dihydroquinidinyl)phthalazine hydroquinidine 1,4-phathalazinediyl diether
bis-DPHP cpd
spleen tyrosine kinase (SYK) inhibitor C61
Registry Numbers
0
Heading Mapped to
*Phthalazines
Frequency
3
Source
Anticancer Drugs . 2020 Jul;31(6):609-616.
Date of Entry
2021/03/26
Revision Date
2022/11/21
(SYK) inhibitor C61 Preferred
1,4-Bis (9-O dihydroquinidinyl) phthalazine-hydroquinidine 1,4-phathalazinediyl diether Broader
page delivered in 0.003s